Geistlich Expands its Partnership with Meisinger and Launches the Master-Pin-Control System
FOR IMMEDIATE RELEASE
February 4, 2026
Geistlich Expands its Partnership with Meisinger – Launches the Master Pin Control Kit, Pin System
PRINCETON, NJ — Geistlich Pharma North America is proud to announce the expansion of its collaboration with Meisinger through the launch of the Master-Pin-Control Kit, a precision fixation system designed to further enhance outcomes in regenerative dental procedures.
Developed by Dr. Istvan Urban, the Master-Pin-Control system is specifically engineered for the fixation of resorbable, non-resorbable, and titanium membranes. Crafted from Grade 5 titanium alloy, each pin features a small groove design that allows it to be inserted like a pin and easily removed like a screw.
The sharp tip and robust structure enable precise placement into cortical bone, and the innovative threading ensures easy, safe removal after successful healing. This innovative design allows clinicians to achieve more secure membrane fixation and reduces the risk of complications.
“Our partnership with Meisinger continues to deliver meaningful innovation to our customers,” said Les Burrows, General Manager of Geistlich Pharma North America. “The opportunity to add the Master-Pin-Control system to our growing biomaterials product portfolio is exciting and enhances our fixation system products for our customers.”
“Our partnership with Meisinger continues to deliver meaningful innovation to our customers.”
— Les Burrows, General Manager, Geistlich Pharma North America
About Meisinger
As one of the oldest and most efficient manufacturers of dental rotary instruments, MEISINGER has always been a pioneer in the field of precision work. With a consistent focus on the needs of dental practices and dental laboratories, Meisinger has assumed a leading position in the dental industry.
About Geistlich North America Inc.
With 175 years of regenerative expertise, Geistlich continues to set the global standard in oral regeneration. The company offers a comprehensive portfolio of clinically proven biomaterials, including the world-renowned Geistlich Bio-Oss® and a full line of allografts under the vallos® brand.
The resorbable collagen membrane Geistlich Bio-Gide® is now available in a compressed version for varied handling preferences. For soft-tissue regeneration, Geistlich Mucograft® and Geistlich Fibro-Gide® provide scientifically validated alternatives to autogenous grafts. GEM 21S®, a growth-factor-enhanced matrix, rounds out the portfolio with targeted support for wound healing and bone regeneration.
Geistlich’s legacy of scientific collaboration, product excellence, and clinical outcomes is what makes Geistlich Biomaterials Exactly Like No Other.
Media Contact:
Jamie Bratton
[email protected]
Geistlich Pharma North America Inc.
400 Alexander Park Drive, Suite 302
Princeton, NJ 08540 USA
Home Page:
Social Media
